Viewing StudyNCT00725764



Ignite Creation Date: 2024-05-05 @ 7:43 PM
Last Modification Date: 2024-10-26 @ 9:53 AM
Study NCT ID: NCT00725764
Status: COMPLETED
Last Update Posted: 2017-10-16
First Post: 2008-07-28

Brief Title: Phase 2 Study of GSK1363089 Formerly XL880 in Adults With Squamous Cell Cancer of the Head and Neck
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Neoplasms Head and Neck
Keywords:
Name View
VEGFR2 View
XL880 View
foretinib View
Squamous Cell Cancer of the Head and Neck View
MET View
GSK1363089 View